Who is sponsoring NCT04452396?

NCT04452396 is sponsored by Barts & The London NHS Trust.

What drugs are being tested in NCT04452396?

Interventions in NCT04452396: use of continuous glucose monitoring.

What condition does NCT04452396 study?

NCT04452396 studies Hypoglycemia, Reactive, Hypoglycaemia Night, Hypoglycemia Non-Diabetic, Hypoglycemia Unawareness, Insulinoma, Insulinoma; Malignant, Pancreas, Insulin Hypoglycemia, Insulin Resistance, Spontaneous Hypoglycemia, Neuro Endocrine Tumours.

Is NCT04452396 still recruiting?

NCT04452396 is currently terminated. Last updated 12 December 2023.

Last reviewed 2023-12-12 · How we verify

NCT04452396

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia

Terminated NA Last updated 12 December 2023

What this trial tests

NA trial testing use of continuous glucose monitoring in Hypoglycemia, Reactive in 7 participants. Terminated before completion.

Timeline

1 December 2019

Primary endpoint
1 March 2020

31 January 2023

Quick facts

Lead sponsor	Barts & The London NHS Trust
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	7
Start date	1 December 2019
Primary completion	1 March 2020
Estimated completion	31 January 2023
Sites	1 location across United Kingdom

Drugs / interventions tested

use of continuous glucose monitoring

Conditions studied

Hypoglycemia, Reactive — all drugs for Hypoglycemia, Reactive →
Hypoglycaemia Night — all drugs for Hypoglycaemia Night →
Hypoglycemia Non-Diabetic — all drugs for Hypoglycemia Non-Diabetic →
Hypoglycemia Unawareness — all drugs for Hypoglycemia Unawareness →

Sponsor

Barts & The London NHS Trust — full company profile →

Who can join

Adults 18 to 90, any sex, with Hypoglycemia, Reactive or Hypoglycaemia Night. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Use of CGM to determine diagnosis in possible spontaneous or reactive hypoglycaemia. Use of CGM to aid treatment optimisation in spontaneous or reactive hypoglycaemia

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hypoglycemia, Reactive

Currently open trials in the same condition.

NCT06986603 — Glucagon Dose-Response in Patients With Post-Bariatric Hypoglycemia · Phase 4 · active not recruiting

Other Barts & The London NHS Trust trials

Trials by the same sponsor.

NCT05753085 — Multimodality Optical and Ultrasound Intravascular Imaging for Stent Optimization and Atheroma Assessment · NA · withdrawn
NCT07047235 — Substrate Remodelling and Targeted Ablation in AF · NA · recruiting
NCT06871215 — Inflammation and Infective Endocarditis · withdrawn
NCT07076524 — MuScle WastIng and DysphaGia iN CriticAlly IlL Patients (SIGNAL) · recruiting
NCT06596486 — A Comparison of CoolStick With Ethyl Chloride for the Assessment of Light Touch · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04452396 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Barts & The London NHS Trust
Last refreshed: 12 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04452396.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing